Humana Inc vs Yum China Holdings Inc — how do they compare? Humana Inc trades at $434.95 (market cap $46.49B), while Yum China Holdings Inc trades at $42.86 (market cap $14.11B). The key difference: Humana Inc is far larger — about 3.3× Yum China Holdings Inc's market cap, and Yum China Holdings Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Yum China Holdings Inc for 77 Days on average.
| HUM | YUMC | |
|---|---|---|
Market Cap | $46.49B | $14.11B |
Volume | 2,567,704 | 2,350,650 |
Sector | Health | Consumer Cyclical |
52-Week High | $409.85 | $57.95 |
52-Week Low | $163.67 | $39.98 |
Typical Hold Time | 53 Days | 77 Days |
Enterprise Value | $53.84B | $15.02B |
Dividend Yield | 0.91% | 2.78% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.
The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.
YUMC trades at $40.65 with minimal daily movement (+0.07%). The stock shows strong fundamental performance with consistent earnings beats (Q4 2025-Q2 2026) and solid profitability metrics (ROE 17.5%, net margin 7.84%). Recent business developments include the acquisition of Pizza Hut brand ownership in mainland China and expansion of Pizza Hut Burger Bar to 300 locations. Technical indicators show bearish momentum with the stock trading near key support at $40.
YUMC presents a compelling value opportunity with reasonable valuation multiples (P/E 15.3, P/S 1.2) and strong analyst support (73.68% buy ratings). Upside potential exists from continued store expansion and brand innovation, though investors should monitor China's consumer spending trends and competitive pressures in the restaurant sector. The stock's current technical weakness may offer entry points for long-term investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →With almost 10,600 units and USD 9.5 billion in systemwide sales in 2020, Yum China is the largest restaurant chain in China. It generates revenue through its own restaurants and franchise fees. Key concepts include KFC (7,166 units) and Pizza Hut (2,355), but the company's portfolio also includes other brands such as Little Sheep, East Dawning, Taco Bell, Huang Ji Huang, COFFii & Joy, and Lavazza (collectively representing about 985 units). Yum China is a trademark licensee of Yum Brands, paying 3% of total systemwide sales to the company it separated from in October 2016.
Read more on YUMC →